Stephen V. Liu, MD - Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes

Stephen V. Liu, MD - Building a Better Backbo...

‏التالي

Prof. David Planchard, MD, PhD - From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE informati ...  عرض المزيد

Erika Hamilton, MD / Tiffany A. Traina, MD, FASCO - Practice Readiness for TROP2-Targeting ADCs in First-Line TNBC: Right Patient, Right Time, Right Team

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE informatio ...  عرض المزيد

‏حلقات موصى بها

Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The treatment arsenal for NSCLC with and without genomic alterations is continuously growing, and novel HER2-, HER3-, and TROP2-targeting antibody– ...  عرض المزيد

Michael Heinrich, MD - Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/CPH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While TKIs have been a mainstay in the first three lines of treatment for patients with gastrointestinal stromal tumors (GISTs), new discoveries a ...  عرض المزيد

Jacob Sands, MD - Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/VDU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Small cell lung cancer (SCLC) is known as an aggressive, rapidly progressing, and challenging thoracic malignancy. After lacking progress for decad ...  عرض المزيد

Anthony R. Mato, MD, MSCE - The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/QXD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Despite the success of BTK inhibitor therapy in B-cell malignancies, therapeutic resistance and intolerance represent barriers to effective, sustai ...  عرض المزيد